The effects of a stroke can be extremely severe and can include difficulties in motor skills, paralysis, fatigue, memory loss, dementia, and aphasia. Aphasia is the damage of the portion of the brain that is associated with communication and language. Namely, Broca's area or Wernicke's area are damaged. Aphasia is largely caused by stroke because when the stroke occurs blood cannot get to the brain tissue and it will die. Aphasia, however can be reduced and the function and ability to speak effectively can be regained through aphasia therapy. Many stroke patients will undergo aphasia therapy, which includes two different categories of treatment style. One is called impairment-based and the other is called communication-based. Impairment-based treatment generally aims to improve skills like listening, speaking, and reading/writing. Communication-based focuses on actual interpersonal interactions and situations where communicating is essential.
The AHA/ASA published an article that looked at the correlation between the intensity of the aphasia treatment and the improvement from the treatment. Essentially, this was a literature search where the researchers found several clinical trials of various treatment lengths and their results and compared them. The values for how well a patient improved was compared by the Porch Index of Communicative Ability (PICA) test and the Functional Communication Profile (FCP). These are ways of evaluating a persons speaking and communication abilities. The study found that the length of the therapy per week (in hours) and total hours of therapy was directly correlated to improvement on the PICA. This shows that a higher intensity therapy program yields much better results for the patients. They found that an average of about 8-9 hours of therapy per week yielded significantly improved results to that of 2 hours of therapy per week.
It's interesting to me that there are such great differences in therapy lengths for aphasia treatment instead of a standard range of therapy lengths and intensities. The issues with creating a standard treatment, like for example saying that a patient with aphasia will be put on a treatment program of 8 hours a week for 12 weeks, would be the same that physical therapy has. There are differences in patient motivation and commitment that stop something like this from becoming a reality. It would be beneficial because of the clear improvement, but actual enforcement of it would be difficult due to that fact that not everyone is as motivated to get better as maybe they should be. Being the type of person that I am, I would definitely be opting for the longer, more intensive treatments because communication skills are essential in everyday life and being deficient in them would be very frustrating to deal with.
SOURCES
Bhogal, S. K.. "Intensity of Aphasia Therapy, Impact on Recovery * Aphasia Therapy Works!." Stroke 34.4 (2003): 987-993. Stroke. Web. 12 Oct. 2014. https://stroke.ahajournals.org/content/34/4/987.full.pdf+html
http://www.aphasia.org/content/aphasia-therapy-guide
Sunday, October 12, 2014
Wednesday, October 8, 2014
Increased Risk of Stroke in HIV/AIDS Individuals
After the in class discussion of T and B cells and their relation to stroke size and inflammation, I began to wonder: “How do
HIV/AIDS patients fare when it comes to stroke? Since T cell mediated cytokine
release and stroke lesion size are proportional, then does that mean that in a
HIV/AIDS patient who has compromised T cell levels, his/her incident of stroke
would be decreased?” Unfortunately,
after some research, it appears that having HIV/AIDS actually increases the
risk of not only ischemic stroke, but also hemorrhagic stroke. The most
striking aspect? This increased risk of stroke in HIV/AIDS patients seems to be
most prevalent in young diseased populations that display none of the
traditional stroke risk factors: high cholesterol, tobacco use and smoking,
obesity, and diabetes.
So if they aren’t at risk for stroke in the traditional
sense, then what’s causing the increased incidence of stroke in young HIV/AIDS
patients? The tentative answer is vascular remodeling and cardioembolic
conditions. Studies show that HIV/AIDS patients display higher rates of
atherosclerosis, the hardening of arteries due to plaque build up. The
increased rate of atherosclerosis is casually correlated with the vascular
remodeling that HIV/AIDS individuals present with. Moreover, these atherosclerotic
conditions facilitate the development of cardiomyopathies such as marantic
endocarditis (growth on the heart valves), myxoid valvular degeneration
(weakening of connective tissue in heart valves), dilated cardiomyopathy (an
enlarged and weakened heart that cannot efficiently eject blood), and
myocardial infarction (heart attack). As a result, the risk of stroke in diseased
patients is significantly increased upon having these conditions.
As if being at higher risk for stroke wasn’t enough, it is
extremely difficult to treat HIV/AIDS individuals once they experience stroke,
since there is little information/limited treatment available. Currently, we
know little about the effects of traditional stroke therapy (anticoagulants,
blood pressure lowering drugs) on the antiretroviral already prescribed to
HIV/AIDS patients. Consequently, there is currently no specific treatment for
HIV/AIDS individuals who experience stroke.
Sources:
"Am I at Risk for a Stroke?" Stroke Risk Factors. National Stroke Association, 2014. Web. 05 Oct. 2014.
Dobbs, Michael R., and Joseph R. Berger. "Stroke in HIV Infection and AIDS." Expert Review of Cardiovascular Therapy 7.10 (2009): 1263-271. Web.
Monday, October 6, 2014
A Whole Bunch of Strokes
So, we have discussed ischemic and hemorrhagic strokes. Just as a reminder, while you are reading this, an ischemic stroke is when there is a clot causing obstruction in a blood vessel for the brain. There is cerebral thrombosis, where there is a blood clot formed in the vessel in the brain, but there is also a cerebral embolism, where the clot originally formed in another location in the body and a small piece broke off and found its way to the brain's blood vessel. There is also silent cerebral infarction where a blood clot most likely formed from a brain injury. This form of stroke can be a risk factor for future strokes as well.
Hemorrhagic strokes are where a weakened blood vessel ruptures and bleeds into the brain. As the blood accumulates there is an increase in pressure and the surrounding tissue will start to get compressed. There are also two types of hemorrhagic strokes. There are aneurysms and arteriovenous malformations (AVM). An aneurysm occurs with a ballooning of the weakened vessel and can eventually rupture if it is untreated. AVM is where there is a clump of blood vessels with abnormal anatomy/formation. They can rupture as well. Both ischemic and hemorrhagic strokes are also known as CVAs or cerebrovascular accident.
Now, for the other form of stroke that hasn't really been discussed, transient ischemic attack, or TIA. These are commonly called a "mini" or "warning" stroke and are also the result of a clot. In a TIA, instead of permanent blockage, the clot is only temporarily blocking the blood vessel. The symptoms are similar to a CVA, facial asymmetry, unilateral weakness, and speech change, since you are still depriving a brain region of oxygen. They usually only last a maximum of 5 minutes and on average last about 1 minute. Unlike CVAs there is usually no permanent damage to the brain after a TIA. These are highly associated with future stroke. About 1/3 of the people that have a TIA will have a CVA stroke within a year. TIAs are just as important as stroke in the fact that you can get treatment, such as a minor anti-coagulant, to hopefully prevent further strokes in the future. If you are seen by a physician as soon as the symptoms appear you can be assessed within the time window of 6 hours, just in case of it being a CVA not a TIA. There is no way to tell which clots will dissolve and which won't. So for any stroke symptoms it is best to air on the side of caution.
"Types of Stroke." Types of Stroke. N.p., n.d. Web. 05 Oct. 2014. <http://www.strokeassociation.org/STROKEORG/AboutStroke/TypesofStroke/Types-of-Stroke_UCM_308531_SubHomePage.jsp>.
Hemorrhagic strokes are where a weakened blood vessel ruptures and bleeds into the brain. As the blood accumulates there is an increase in pressure and the surrounding tissue will start to get compressed. There are also two types of hemorrhagic strokes. There are aneurysms and arteriovenous malformations (AVM). An aneurysm occurs with a ballooning of the weakened vessel and can eventually rupture if it is untreated. AVM is where there is a clump of blood vessels with abnormal anatomy/formation. They can rupture as well. Both ischemic and hemorrhagic strokes are also known as CVAs or cerebrovascular accident.
Now, for the other form of stroke that hasn't really been discussed, transient ischemic attack, or TIA. These are commonly called a "mini" or "warning" stroke and are also the result of a clot. In a TIA, instead of permanent blockage, the clot is only temporarily blocking the blood vessel. The symptoms are similar to a CVA, facial asymmetry, unilateral weakness, and speech change, since you are still depriving a brain region of oxygen. They usually only last a maximum of 5 minutes and on average last about 1 minute. Unlike CVAs there is usually no permanent damage to the brain after a TIA. These are highly associated with future stroke. About 1/3 of the people that have a TIA will have a CVA stroke within a year. TIAs are just as important as stroke in the fact that you can get treatment, such as a minor anti-coagulant, to hopefully prevent further strokes in the future. If you are seen by a physician as soon as the symptoms appear you can be assessed within the time window of 6 hours, just in case of it being a CVA not a TIA. There is no way to tell which clots will dissolve and which won't. So for any stroke symptoms it is best to air on the side of caution.
"Types of Stroke." Types of Stroke. N.p., n.d. Web. 05 Oct. 2014. <http://www.strokeassociation.org/STROKEORG/AboutStroke/TypesofStroke/Types-of-Stroke_UCM_308531_SubHomePage.jsp>.
Sunday, October 5, 2014
Aspirin: A Risk for Hemorrhagic Stroke?
As we discussed in class last week
and Allison also mentions in her blog, there are two main classes or types of
stroke. They are hemorrhagic and
ischemic; ischemic is the vast majority of all stroke cases. It accounts for about 87% of stroke cases
according to www.strokeassociation.org. Ischemic stroke is where there is a blockage
in the blood vessel. Hemorrhagic stroke
is where a blood vessel around the brain is ruptured and bleeding around or in
the brain occurs. This rupture is called
an aneurysm. This post will be focusing
on hemorrhagic stroke. It will also
discuss aspirin, a common drug given to aid prevention of cardiovascular and
ischemic occurences, and its possibility as a risk factor for hemorrhagic
stroke. Hemorrhagic stroke is more
uncommon than ischemic, but it has a higher fatality rate.
Inside of
the category of hemorrhagic stroke, there are two subgroups. These are intracerebral hemorrhage and
subarachnoid hemorrhage. Intracerebral is
exactly what it sounds like; it is bleeding inside of the brain. Subarachnoid hemorrhage is bleeding in the
space between the brain and the skull.
Blood causes brain tissue irritation and swelling. A common cause for hemorrhagic stroke is high
blood pressure, which eventually causes enough stress on the arteries that they
rupture. Testing for hemorrhagic stroke
is usually accomplished by a CT scan of the brain. This will show the hemorrhage, if there is
one in the brain. An MRI can also be
used, however CT scans are the most common way to determine a hemorrhage in the
brain.
As many of
us know, aspirin is a very common drug given to people who want to prevent
heart disease, ischemic stroke, and heart attacks. Aspirin is an NSAID and it has an effect on
platelets that leads to a decrease in their aggregation. This decrease in platelet aggregation means
there is less chance a blockage will form.
More specifically, aspirin bind irreversibly to platelet COX-1,
cyclooxygenase-1, to inhibit it. COX-1 is
a vasoconstrictor and causes platelet aggregation (Stroke, pg 1801). This means that should bleeding occur, it
will be much harder to stop because clots are less likely to form. This makes sense then, that aspirin could be
a risk factor for hemorrhagic stroke and other bleeding events. The article “Risk of Hemorrhagic Stroke With
Aspirin Use” discusses aspirin and resulting trials to test for an increased
risk of hemorrhagic stroke when the patients were using aspirin. They found that “in 11 of the 13 trials
reporting hemorrhagic stroke, aspirin was associated with an increase in
absolute risk of hemorrhagic stroke” (Stroke, 1802). They also discuss that hypertension is the
leading cause of hemorrhagic stroke, and state that the magnitude of the
benefit in reducing blood pressure from aspirin far outweighs the risk. It seems to me that since hypertension is
such a large part in inducing hemorrhages in the brain, that although aspirin
could be a risk factor for hemorrhagic stroke, its role at reducing blood
pressure and preventing heart attack and ischemia is much more valuable and
important. It is definitely something to
think about as far as a risk factor for this type of stroke, however I do think
that the good benefits from aspirin outweigh the very low risk of hemorrhagic
stroke.
References
Gorelick, P. B.. "Risk Of Hemorrhagic Stroke With Aspirin Use: An Update."Stroke 36.8 (2005): 1801-1807. http://stroke.ahajournals.org/content/36/8/1801.full.pdf+html
http://www.nytimes.com/health/guides/disease/hemorrhagic-stroke/overview.html
http://www.uptodate.com/contents/hemorrhagic-stroke-treatment-beyond-the-basics
Friday, October 3, 2014
What a bleeder...
As we have talked about in class, there are two types of stroke: hemorrhagic and ischemic. Hemorrhagic is a massive bleed in the brain while ischemic is from a clot blocking off a vessel so that there is lack of oxygenation of an area of brain tissue. When someone comes to the emergency department with symptoms like unilateral weakness, facial asymmetry, and/or slurred speech; one of the first thoughts is stroke. A head CT is ordered as emergent and neurology is at bedside almost immediately, every now and then they beat the patient to the room. If it is determined that it is an ischemic stroke and is within 6 hours of known symptom onset, among other qualification such as medical history, the patient could be eligible for TPA, Tissue Plasminogen Activator.
TPA is an IV anti-coagulant that is given to dissolve the clot and thus allow blood flow to return to that area of the brain. Maximum efficient of the drug is noted if it is given as close to the onset of symptoms as possible. One of the most crucial factors for stroke is time. If you wait too long, there can be other cellular damage from the clot that would make the return of blood flow to that area, with the use of TPA, very dangerous and could cause potential bleeding in the cranium/brain (depends where the clot is located). The biggest concern with the medication is internal bleeding. Because of how potent the drug is, there is a very specific dosage a patient can received based on the person's weight and prior medications. If a patient is already taking blood thinners, such as Coumadin, it would be highly risky to give them the same dosage as someone who is not taking a blood thinner. Other side effects are fever and low blood pressure. Personally, while in the ED I have only seen TPA given 1-2 times over the past 2 years. It is very difficult to meet all the qualifications to be eligible to receive TPA.
If TPA is administered, as requested usually by the neurologist that is at bedside, the patient is admitted and is VERY carefully monitored with repeat INR (international normalization ratio), clotting measurement lab study, to make sure it decreases correctly over time. a CBC, complete blood count will also be frequently rechecked to monitor hemoglobin and hematocrit levels. They will also check leukocyte counts with the CBC to check for underlying infections as well.
"Tissue Plasminogen Activator (t-PA) for Stroke." WebMD. WebMD, n.d. Web. 03 Oct. 2014. <http://www.webmd.com/stroke/tissue-plasminogen-activator-t-pa-for-stroke>.
***other information came from talking with TMC neurologists and ED physicians on patient stroke (neuro-red) cases***
TPA is an IV anti-coagulant that is given to dissolve the clot and thus allow blood flow to return to that area of the brain. Maximum efficient of the drug is noted if it is given as close to the onset of symptoms as possible. One of the most crucial factors for stroke is time. If you wait too long, there can be other cellular damage from the clot that would make the return of blood flow to that area, with the use of TPA, very dangerous and could cause potential bleeding in the cranium/brain (depends where the clot is located). The biggest concern with the medication is internal bleeding. Because of how potent the drug is, there is a very specific dosage a patient can received based on the person's weight and prior medications. If a patient is already taking blood thinners, such as Coumadin, it would be highly risky to give them the same dosage as someone who is not taking a blood thinner. Other side effects are fever and low blood pressure. Personally, while in the ED I have only seen TPA given 1-2 times over the past 2 years. It is very difficult to meet all the qualifications to be eligible to receive TPA.
If TPA is administered, as requested usually by the neurologist that is at bedside, the patient is admitted and is VERY carefully monitored with repeat INR (international normalization ratio), clotting measurement lab study, to make sure it decreases correctly over time. a CBC, complete blood count will also be frequently rechecked to monitor hemoglobin and hematocrit levels. They will also check leukocyte counts with the CBC to check for underlying infections as well.
"Tissue Plasminogen Activator (t-PA) for Stroke." WebMD. WebMD, n.d. Web. 03 Oct. 2014. <http://www.webmd.com/stroke/tissue-plasminogen-activator-t-pa-for-stroke>.
***other information came from talking with TMC neurologists and ED physicians on patient stroke (neuro-red) cases***
Wednesday, October 1, 2014
Stem Cells, The Blood Brain Barrier, and the Future
In the article, "Snorting Stem Cells", we reviewed earlier this week, we learned that there was a significant effort in 2009 towards developing a method for delivering stem cells to the brain, notably through "snorting" (for lack of better word). However, as interesting and hopeful as the article was, it failed to address some important questions that were brought up during discussion, such as: "What happens when the blood brain barrier, something designed to keep self and foreign particles, is made more permeable in order to retain a greater proportion of stem cells post-snorting?" And: "What happens once the stem cells reach the brain? Stem cells themselves have no therapeutic ability unless induced to differentiate and mature into potentially beneficial cells, so how do we get them to differentiate?" Obviously, I don't have the answers to these questions, but the purpose of this blog is to facilitate discussion, so let's start with a general overview on the blood brain barrier and stem cell function.
Discovered over 100 years ago by one Paul Ehrlich, the blood brain barrier serves to protect the brain from foreign (antigens, toxins) and self particles (leukocytes, macrophages) in the blood. Ehrlich found that upon administering different dyes through the blood, all major organs would stain, with the exception of the brain. Thus, the idea of a blood brain barrier existing was born. Today, we know that the barrier is primarily mediated by tight junctions and astrocytes. The tight junctions of the barrier are found in capillary endothelial cells, and serve to selectively limit the diffusion of non neural molecules. The astrocytes maintain the barrier through release of certain chemical messengers, and maintain the brain water uptake through aquaporin-4 water channels. Most importantly, however, was the discovery that molecules could make it across the blood brain barrier if they were lipid soluble enough, thus allowing for transport by diffusion. In fact, this is how many psychoactive drugs enter the brain.
Remarkably distinctive from other cells, are stem cells. Characterized by their ability to divide into virtually any cell our body needs, stem cells are pluripotent and non-specialized. There are two types of stem cells currently known: embryonic and adult stem cells. Both retain the basic function of stem cells described above, with greatest difference in location and specificity of division. Embryonic stem cells possess the ability to divide into the three primary germ line layers: the ectoderm, mesoderm and endoderm, which in turn divide into the cells that our body is comprised of. Adult stem cells are more rare and limited in their ability to divide-- they are usually found in more tissue/organ specific areas and can only divide into cells respective to their location. For example, hepatic stem cells will only be able to develop into other hepatic cells.
So how does this all relate to the questions posed in class? Well if you remember, in the article they stated that an enzyme was given to increase the permeability of the blood brain barrier. We decided that this was dangerous, since we don't know what else could make it in. Considering that the amount of stem cells that made it into the brain was such a meager amount (500/300,000) to begin with, a 3 fold increase claimed by increasing barrier permeability can be considered negligible. Furthermore, when taking into account the rapid division ability of stem cells, only a small amount would be localized in the brain to induce a larger, therapeutic effect. Also, since the blood brain barrier allows molecules in by diffusion based on their liposolubility, an interesting path for future research could be along the lines of trying to increase the lipid solubility of stem cells. Secondly, the question of how the adult stem cells would differentiate once in the brain could be answered upon inspection of stem cell behavior. As stated above, adult stem cells usually divide into cells in the organ in which they are found. So by snorting stem cells and allowing them to enter the brain, one might be able to trust that they divide into brain cells, right? Well, for individuals who have damaged brain tissue from incidences such as stroke, the snorted stem cells could act as a repair mechanism in which new neural tissue could be regenerated in areas that the stem cells were localized.
Ultimately, this is just all food for thought. It can't be denied that stem cell/blood brain barrier research is still in its infancy and has vast reservoirs of untapped knowledge to be found.
Sources:
Discovered over 100 years ago by one Paul Ehrlich, the blood brain barrier serves to protect the brain from foreign (antigens, toxins) and self particles (leukocytes, macrophages) in the blood. Ehrlich found that upon administering different dyes through the blood, all major organs would stain, with the exception of the brain. Thus, the idea of a blood brain barrier existing was born. Today, we know that the barrier is primarily mediated by tight junctions and astrocytes. The tight junctions of the barrier are found in capillary endothelial cells, and serve to selectively limit the diffusion of non neural molecules. The astrocytes maintain the barrier through release of certain chemical messengers, and maintain the brain water uptake through aquaporin-4 water channels. Most importantly, however, was the discovery that molecules could make it across the blood brain barrier if they were lipid soluble enough, thus allowing for transport by diffusion. In fact, this is how many psychoactive drugs enter the brain.
Remarkably distinctive from other cells, are stem cells. Characterized by their ability to divide into virtually any cell our body needs, stem cells are pluripotent and non-specialized. There are two types of stem cells currently known: embryonic and adult stem cells. Both retain the basic function of stem cells described above, with greatest difference in location and specificity of division. Embryonic stem cells possess the ability to divide into the three primary germ line layers: the ectoderm, mesoderm and endoderm, which in turn divide into the cells that our body is comprised of. Adult stem cells are more rare and limited in their ability to divide-- they are usually found in more tissue/organ specific areas and can only divide into cells respective to their location. For example, hepatic stem cells will only be able to develop into other hepatic cells.
So how does this all relate to the questions posed in class? Well if you remember, in the article they stated that an enzyme was given to increase the permeability of the blood brain barrier. We decided that this was dangerous, since we don't know what else could make it in. Considering that the amount of stem cells that made it into the brain was such a meager amount (500/300,000) to begin with, a 3 fold increase claimed by increasing barrier permeability can be considered negligible. Furthermore, when taking into account the rapid division ability of stem cells, only a small amount would be localized in the brain to induce a larger, therapeutic effect. Also, since the blood brain barrier allows molecules in by diffusion based on their liposolubility, an interesting path for future research could be along the lines of trying to increase the lipid solubility of stem cells. Secondly, the question of how the adult stem cells would differentiate once in the brain could be answered upon inspection of stem cell behavior. As stated above, adult stem cells usually divide into cells in the organ in which they are found. So by snorting stem cells and allowing them to enter the brain, one might be able to trust that they divide into brain cells, right? Well, for individuals who have damaged brain tissue from incidences such as stroke, the snorted stem cells could act as a repair mechanism in which new neural tissue could be regenerated in areas that the stem cells were localized.
Ultimately, this is just all food for thought. It can't be denied that stem cell/blood brain barrier research is still in its infancy and has vast reservoirs of untapped knowledge to be found.
Sources:
"Blood Brain Barrier and Cerebral Metabolism." Blood Brain Barrier and Cerebral Metabolism. UT Texas Medical School, n.d. Web. 30 Sept. 2014.
"Frequently Asked Questions." Stem Cell Basics: Introduction [Stem Cell Information]. National Institute of Health, n.d. Web. 29 Sept. 2014.
Morrison, Deanne. "Snorting Stem Cells." : UMNews : University of Minnesota. N.p., n.d. Web. 01 Oct. 2014.
Monday, September 29, 2014
Fatty Liver Disease
The journal we read pertaining to the young adult obese subjects in Italy brought to attention non-alcoholic fatty liver disease. We know that obesity is a leading risk factor in the development of type 2 diabetes, but it also plays a major role in liver disease. There are two types of fatty liver disease: alcoholic liver disease and non-alcoholic liver disease. From previous courses you may know that some fat in the liver is normal, however even a small percentage of total liver weight consisting of fat can be detrimental.
Alcoholic liver disease is brought upon by consuming large amounts of alcohol. These copious amounts can deter the liver enzymes responsible for alcohol metabolism. An increase in visceral fat also affects these enzymes and promotes liver disease. Non-alcoholic liver disease is caused mainly from obesity, which enlarges the liver to the point that the cells cannot properly work. The liver has an issue with breaking down fats, and because of this they begin to build up in the tissue. As we know, with increasing obesity comes the development of type 2 diabetes, helping in the formation of non-alcoholic fatty liver disease. In fact, "more than two thirds of people with diabetes develop non-alcoholic fatty liver disease." Obesity leads to increased cholesterol and triglycerides, and the development of insulin resistance.
Sources:
http://www.medicinenet.com/fatty_liver/page4.htm#what_is_the_relationship_between_nonalcoholic_fatty_liver_disease_obesity_and_diabetes
http://www.webmd.com/hepatitis/fatty-liver-disease
http://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/basics/causes/con-20027761#
Alcoholic liver disease is brought upon by consuming large amounts of alcohol. These copious amounts can deter the liver enzymes responsible for alcohol metabolism. An increase in visceral fat also affects these enzymes and promotes liver disease. Non-alcoholic liver disease is caused mainly from obesity, which enlarges the liver to the point that the cells cannot properly work. The liver has an issue with breaking down fats, and because of this they begin to build up in the tissue. As we know, with increasing obesity comes the development of type 2 diabetes, helping in the formation of non-alcoholic fatty liver disease. In fact, "more than two thirds of people with diabetes develop non-alcoholic fatty liver disease." Obesity leads to increased cholesterol and triglycerides, and the development of insulin resistance.
Sources:
http://www.medicinenet.com/fatty_liver/page4.htm#what_is_the_relationship_between_nonalcoholic_fatty_liver_disease_obesity_and_diabetes
http://www.webmd.com/hepatitis/fatty-liver-disease
http://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/basics/causes/con-20027761#
Subscribe to:
Posts (Atom)